News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ProMetic Life Sciences Inc. (PFSCF.PK): Results Of Pathogen Removal and Diagnostic Technologies Inc.'s Brain Spike Study Published In Transfusion


7/13/2006 12:33:31 PM

Pathogen Removal and Diagnostic Technologies Inc. ("PRDT"), and its co-development, commercial and manufacturing partner MacoPharma SA ("MacoPharma") announced that Transfusion, the American Association of Blood Banks' monthly peer-reviewed journal and a leading scientific publication in the field of blood transfusion medicine, published in its July issue the results of an extensive study sponsored by PRDT. PRDT is a joint venture between ProMetic Life Sciences Inc. (TSX: PLI) and the American Red Cross.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES